Primary cutaneous follicle centre lymphoma Interventions

Primary cutaneous follicle centre lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Primary cutaneous follicle centre lymphoma Interventions On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma Interventions All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Primary cutaneous follicle centre lymphoma Interventions
CDC on Primary cutaneous follicle centre lymphoma Interventions
Primary cutaneous follicle centre lymphoma Interventions in the news
Blogs on Primary cutaneous follicle centre lymphoma Interventions
Directions to Hospitals Treating Splenic marginal zone lymphoma
Risk calculators and risk factors for Primary cutaneous follicle centre lymphoma Interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2] Soroush Seifirad, M.D.[3]

Overview

There are no recommended therapeutic interventions for the management of primary cutaneous follicle centre lymphoma.

OR

[Name of intervention] is not the first-line treatment option for patients with primary cutaneous follicle centre lymphoma. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for primary cutaneous follicle centre lymphoma is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.

OR

[Name of intervention] is the mainstay of treatment for [disease or malignancy].

Indications

The mainstay of treatment for TT is medical therapy.